skip to main content


Strategic Investment and Merger for CyVek, Inc.

CyVek, Inc.

Shipman & Goodwin, which has been engaged by CyVek since its formation in 2008, is proud to have served as CyVek’s trusted legal counsel in the strategic transaction with Techne Corporation, the most important transaction in CyVek’s corporate history. The firm’s legal team included Dormer Stephen, Donna Brooks, Matt Monteith and Miriam Lewis.

CyVek’s CyPlexTM technology integrates an innovatively designed microfluidic cartridge with a state-of-the-art analyzer to deliver the most advanced and efficient bench top immunoassay system. CyPlex’sTM ability to provide "sample to answer" test results precisely and quickly in a sealed disposable device makes it a very attractive platform for clinical applications. The CyPlexTM technology has demonstrated broad applicability across numerous sectors, including routine life sciences research applications.

For more information, read the Techne Corporation press release.

© Shipman & Goodwin LLP 2020. All Rights Reserved.